Oncogene

Oncogene is a leading international peer-reviewed journal dedicated to the study of the molecular and cellular mechanisms underlying cancer development and progression. Published by Springer Nature, the journal has an ISSN of 0950-9232 and holds a distinguished 2026 Impact Factor of 9.100, placing it firmly within the top tier (Q1) of the JCR Cell Biology and Oncology categories. The journal’s scope encompasses the full spectrum of cancer research, with a strong emphasis on the structure and function of oncogenes, tumor suppressor genes, and gene regulatory networks. Core topics include signal transduction, cell cycle control, apoptosis, genomic instability, metastasis, and the molecular basis of therapeutic resistance. Oncogene primarily publishes Original Research Articles that present significant mechanistic insights, alongside Review Articles, Perspectives, and Short Communications that highlight emerging concepts and technologies. Its target audience comprises academic researchers, clinical oncologists, and pharmaceutical scientists seeking cutting-edge discoveries in basic and translational cancer biology. A notable feature is its hybrid open access model, allowing authors to publish either via subscription or open access (Creative Commons licenses), thereby maximizing dissemination and impact. As a flagship journal in the field, Oncogene is widely recognized for its rigorous peer review, high citation rates, and consistent Q1 ranking, making it an essential resource for advancing the understanding of cancer genetics and for informing the development of novel targeted therapies.